Search

Jennifer Sue Pitrak Mcdonald

Examiner (ID: 18643, Phone: (571)270-3061 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1609, 3796, 3792, 1635, 1674
Total Applications
600
Issued Applications
220
Pending Applications
26
Abandoned Applications
355

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5739019 [patent_doc_number] => 20060009410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Effects of apolipoprotein B inhibition on gene expression profiles in animals' [patent_app_type] => utility [patent_app_number] => 11/123656 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41573 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009410.pdf [firstpage_image] =>[orig_patent_app_number] => 11123656 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/123656
Effects of apolipoprotein B inhibition on gene expression profiles in animals May 4, 2005 Abandoned
Array ( [id] => 7172218 [patent_doc_number] => 20050203049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => '47169 and 33935, novel human glycosyl transferases and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/120749 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 39128 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203049.pdf [firstpage_image] =>[orig_patent_app_number] => 11120749 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/120749
47169 and 33935, novel human glycosyl transferases and uses therefor May 2, 2005 Abandoned
Array ( [id] => 4687674 [patent_doc_number] => 20080031855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Anticancer Agent Containing Minus-Strand Rna Virus' [patent_app_type] => utility [patent_app_number] => 11/630522 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15458 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031855.pdf [firstpage_image] =>[orig_patent_app_number] => 11630522 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630522
Anticancer Agent Containing Minus-Strand Rna Virus Apr 27, 2005 Abandoned
Array ( [id] => 5771612 [patent_doc_number] => 20050267063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Antisense modulation of p70 S6 kinase expression' [patent_app_type] => utility [patent_app_number] => 11/117013 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26155 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267063.pdf [firstpage_image] =>[orig_patent_app_number] => 11117013 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/117013
Antisense modulation of p70 S6 kinase expression Apr 26, 2005 Abandoned
Array ( [id] => 7136686 [patent_doc_number] => 20050181442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'HCaRG, a novel calcium-regulated gene coding for a nuclear protein' [patent_app_type] => utility [patent_app_number] => 11/108784 [patent_app_country] => US [patent_app_date] => 2005-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15252 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181442.pdf [firstpage_image] =>[orig_patent_app_number] => 11108784 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/108784
HCaRG, a novel calcium-regulated gene coding for a nuclear protein Apr 18, 2005 Abandoned
Array ( [id] => 5247831 [patent_doc_number] => 20070244065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Composition Comprising a Survivin Oligonucleotide and Gemcitabine for The Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 11/587219 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4700 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244065.pdf [firstpage_image] =>[orig_patent_app_number] => 11587219 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/587219
Composition Comprising a Survivin Oligonucleotide and Gemcitabine for The Treatment of Cancer Apr 14, 2005 Abandoned
Array ( [id] => 7005111 [patent_doc_number] => 20050170424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Gankyrin' [patent_app_type] => utility [patent_app_number] => 11/083944 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19130 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170424.pdf [firstpage_image] =>[orig_patent_app_number] => 11083944 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/083944
Gankyrin Mar 20, 2005 Issued
Array ( [id] => 5760055 [patent_doc_number] => 20060211000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Methods, compositions, and kits for detection of microRNA' [patent_app_type] => utility [patent_app_number] => 11/084082 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 22361 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211000.pdf [firstpage_image] =>[orig_patent_app_number] => 11084082 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/084082
Methods, compositions, and kits for detection of microRNA Mar 20, 2005 Abandoned
Array ( [id] => 4555112 [patent_doc_number] => 07820809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Functional and hyperfunctional siRNA directed against Bcl-2' [patent_app_type] => utility [patent_app_number] => 11/083784 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 35 [patent_no_of_words] => 50265 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820809.pdf [firstpage_image] =>[orig_patent_app_number] => 11083784 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/083784
Functional and hyperfunctional siRNA directed against Bcl-2 Mar 17, 2005 Issued
Array ( [id] => 7216458 [patent_doc_number] => 20050260163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Triplex hairpin ribozyme' [patent_app_type] => utility [patent_app_number] => 11/081251 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9309 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260163.pdf [firstpage_image] =>[orig_patent_app_number] => 11081251 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/081251
Triplex hairpin ribozyme Mar 15, 2005 Abandoned
Array ( [id] => 7224164 [patent_doc_number] => 20050261225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells' [patent_app_type] => utility [patent_app_number] => 11/081140 [patent_app_country] => US [patent_app_date] => 2005-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6401 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261225.pdf [firstpage_image] =>[orig_patent_app_number] => 11081140 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/081140
Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells Mar 14, 2005 Abandoned
Array ( [id] => 4922751 [patent_doc_number] => 20080071068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Cytoplasmic Localization Dna and Rna' [patent_app_type] => utility [patent_app_number] => 10/589955 [patent_app_country] => US [patent_app_date] => 2005-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8314 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20080071068.pdf [firstpage_image] =>[orig_patent_app_number] => 10589955 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/589955
Cytoplasmic Localization Dna and Rna Feb 20, 2005 Abandoned
Array ( [id] => 5638076 [patent_doc_number] => 20060069050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Methods and compositions for mediating gene silencing' [patent_app_type] => utility [patent_app_number] => 11/060905 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15342 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069050.pdf [firstpage_image] =>[orig_patent_app_number] => 11060905 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/060905
Methods and compositions for mediating gene silencing Feb 16, 2005 Abandoned
Array ( [id] => 7256897 [patent_doc_number] => 20050273868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Methods and compositions for enhancing RISC activity in vitro and in vivo' [patent_app_type] => utility [patent_app_number] => 11/060851 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11200 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20050273868.pdf [firstpage_image] =>[orig_patent_app_number] => 11060851 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/060851
Methods and compositions for enhancing RISC activity in vitro and in vivo Feb 16, 2005 Abandoned
Array ( [id] => 8294607 [patent_doc_number] => 08222393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Polypeptide useful for cancer diagnosis and treatment' [patent_app_type] => utility [patent_app_number] => 11/628056 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12339 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11628056 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/628056
Polypeptide useful for cancer diagnosis and treatment Jan 31, 2005 Issued
Array ( [id] => 6931729 [patent_doc_number] => 20050282764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Method of identifying nucleic acid compositions for muting expression of a gene' [patent_app_type] => utility [patent_app_number] => 11/041797 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13151 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282764.pdf [firstpage_image] =>[orig_patent_app_number] => 11041797 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/041797
Method of identifying nucleic acid compositions for muting expression of a gene Jan 23, 2005 Abandoned
Array ( [id] => 5285385 [patent_doc_number] => 20090099060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Modulation of line-1 reverse transcriptase' [patent_app_type] => utility [patent_app_number] => 10/586434 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13776 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099060.pdf [firstpage_image] =>[orig_patent_app_number] => 10586434 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586434
Modulation of line-1 reverse transcriptase Jan 17, 2005 Abandoned
Array ( [id] => 6952844 [patent_doc_number] => 20050227939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Modulation of kallikrein 6 expression' [patent_app_type] => utility [patent_app_number] => 11/036095 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20492 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227939.pdf [firstpage_image] =>[orig_patent_app_number] => 11036095 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/036095
Modulation of kallikrein 6 expression Jan 13, 2005 Abandoned
Array ( [id] => 6997382 [patent_doc_number] => 20050137160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Antisense modulation of cholesteryl ester transfer protein expression' [patent_app_type] => utility [patent_app_number] => 11/031827 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25896 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137160.pdf [firstpage_image] =>[orig_patent_app_number] => 11031827 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/031827
Antisense modulation of cholesteryl ester transfer protein expression Jan 6, 2005 Abandoned
Array ( [id] => 7039346 [patent_doc_number] => 20050158780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Nucleic acid ligands to the prostate specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 11/029949 [patent_app_country] => US [patent_app_date] => 2005-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10970 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158780.pdf [firstpage_image] =>[orig_patent_app_number] => 11029949 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/029949
Nucleic acid ligands to the prostate specific membrane antigen Jan 3, 2005 Abandoned
Menu